← FDA Drug Approvals (Drugs@FDA)

TYZEKA

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2009-04-28

Drug application

FDA Application #

NDA022154

Application type

New Drug Application

Brand name

TYZEKA

Generic name

Telbivudine

Active ingredients

TELBIVUDINE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

2009-04-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown